c-Rel Antikörper (C-Term)

Produktnummer ABIN545357

Produktdetails anti-c-Rel Antikörper

Target: c-Rel (REL proto-oncogene (c-Rel))

Bindungsspezifität: C-Term

Reaktivität: Human, Maus

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser c-Rel Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA

Verwendungszweck: Rabbit polyclonal antibody raised against synthetic peptide of REL.

Kreuzreaktivität: Human, Maus

Immunogen: A synthetic peptide (conjugated with KLH) corresponding to C-terminus of human REL.

Anwendungsinformationen

Applikationshinweise: ELISA (1:1000)
Western Blot (1:100-500)
The optimal working dilution should be determined by the end user.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: In PBS (0.09 % sodium azide)

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C. For long term storage store at -20°C.
Aliquot to avoid repeated freezing and thawing.

Referenzen für anti-c-Rel Antikörper (ABIN545357)

Houldsworth, Olshen, Cattoretti, Donnelly, Teruya-Feldstein, Qin, Palanisamy, Shen, Dyomina, Petlakh, Pan, Zelenetz, Dalla-Favera, Chaganti: "Relationship between REL amplification, REL function, and clinical and biologic features in diffuse large B-cell lymphomas." in: Blood, Vol. 103, Issue 5, pp. 1862-8, (2004) (PubMed).

Xiao, Shen, Hedvat, Moskowitz, Sussman, Filippa, Zelenetz, Houldsworth, Chaganti, Teruya-Feldstein: "Differential expression patterns of c-REL protein in classic and nodular lymphocyte predominant Hodgkin lymphoma." in: Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry, Vol. 12, Issue 3, pp. 211-5, (2004) (PubMed).

Jain, Ma, Lopez-Granados, Means, Brady, Orange, Liu, Holland, Derry: "Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation." in: The Journal of clinical investigation, Vol. 114, Issue 11, pp. 1593-602, (2004) (PubMed).

Details zu c-Rel

Target: c-Rel (REL proto-oncogene (c-Rel))

Andere Bezeichnung: REL (c-Rel Produkte)

Synonyme: C-Rel antikoerper, c-Rel antikoerper, NFkB antikoerper, c-rel antikoerper, zgc:100833 antikoerper, Xrel2 antikoerper, Xrel3 antikoerper, rel antikoerper, rel-A antikoerper, rel2 antikoerper, rel3 antikoerper, v-rel antikoerper, xrel antikoerper, REL proto-oncogene, NF-kB subunit antikoerper, reticuloendotheliosis oncogene antikoerper, RELA proto-oncogene, NF-kB subunit antikoerper, v-rel avian reticuloendotheliosis viral oncogene homolog antikoerper, v-rel avian reticuloendotheliosis viral oncogene homolog L homeolog antikoerper, ribonuclease A family member 2 pseudogene antikoerper, REL antikoerper, Rel antikoerper, Rela antikoerper, rel antikoerper, rel.L antikoerper, ECRP antikoerper

Gen-ID: 5966